Filed in archive
Drugs, Vaccines and Therapeutics
, Food and Agriculture
, Genomics, Proteomics and Bioinformatics
by ruth on June 7, 2006

Upon approval, ATryn® will be the first antithrombin product approved for use in all 25 countries of the European Union. ATryn® will also be the only available antithrombin product that is produced by recombinant biotechnology and is not derived from the human blood supply.
This is an important milestone, marking the approval of the first recombinant drug produced in a transgenic animal. More details from GTC Biotherapeutics' press release.
Tags:
transgenic
thrombosis
biotech
produced
goat
produced+transgenic
transgenic+goat
therapeutic+produced
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/23721
Mr Wong
Vote for EMEA Approves First Therapeutic Produced in Transgenic Goat:
|
Rating: 7.75 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







